These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6821812)

  • 1. Vincristine, adriamycin, and mitomycin (VAM) therapy for previously treated breast cancer. A preliminary report.
    Oster MW; Park Y
    Cancer; 1983 Jan; 51(2):203-5. PubMed ID: 6821812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin (doxorubicin), vinblastine, and mitomycin C combination chemotherapy in refractory breast carcinoma.
    Luikart SD; Witman GB; Portlock CS
    Cancer; 1984 Oct; 54(7):1252-5. PubMed ID: 6467151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
    Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR
    Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
    Wheeler RH; Baker SR; Liepman MK; Ensminger WD
    Med Pediatr Oncol; 1983; 11(1):12-9. PubMed ID: 6188032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin, mitolactol (dibromodulcitol), and mitomycin C treatment for patients with metastatic breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone (CMFVP).
    DiStefano A; Yap HY; Blumenschein GR
    Cancer Treat Rep; 1981; 65(1-2):33-8. PubMed ID: 7013977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy with mitomycin C, methotrexate, and vincristine (MMV) for metastatic breast cancer refractory to adriamycin].
    Nomura Y; Kanda K; Tashiro H; Hamada Y; Saeki K
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):824-8. PubMed ID: 6411002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin and mitomycin C as initial chemotherapy for advanced breast cancer.
    Amiel SA; Stewart JF; Earl HM; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1984 May; 20(5):631-4. PubMed ID: 6428893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil + Oncovin + Adriamycin + mitomycin C (FOAM): an effective program for breast cancer, even for disease refractory to previous chemotherapy. A Northern California Oncology Group (NCOG) Study.
    Friedman MA; Marcus FS; Cassidy MJ; Resser KJ; Kohler M; Hendrickson CG; Reynolds R; Johnson D; Kilbridge T; Yu K; Cruicitt M
    Cancer; 1983 Jul; 52(2):193-7. PubMed ID: 6344976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer].
    Yasutake K; Imamura Y; Yoshimura Y; Oya M; Matsushita K; Hozumi T; Katou J; Okutani T; Irie K
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2373-9. PubMed ID: 2502072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of advanced breast cancer with two doxorubicin-containing regimens.
    Harris MA; Byrne PJ; Smith FP; Ueno W; Schlesinger C; Oishi S; Schein PS
    Am J Clin Oncol; 1984 Feb; 7(1):51-8. PubMed ID: 6421145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracil.
    Colozza M; Tonato M; Grignani F; Davis S
    Cancer; 1988 Jul; 62(2):262-5. PubMed ID: 3383126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF). A clinical trial of the Piedmont Oncology Association (POA).
    Shipp SK; Muss HB; Westrick MA; Cooper MR; Jackson DV; Richards FC; White DR; Stuart JJ; Christian RM; Ramseur W
    Cancer Chemother Pharmacol; 1983; 11(2):130-3. PubMed ID: 6354509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility study of combining metronidazole with chemotherapy.
    Stewart DJ; Maroun JA; Young V; Crook AF; Hopkins HS; Yan RC; Richard MT; Hugenholtz H; Bélanger R; Heringer R
    J Clin Oncol; 1983 Jan; 1(1):17-23. PubMed ID: 6422002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adriamycin, vincristine and mitomycin C as first and second line therapy for advanced breast carcinoma.
    Harding M; Sangster G; Milsted RA; Kaye SB; Calman KC
    Med Oncol Tumor Pharmacother; 1988; 5(2):125-8. PubMed ID: 3412036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
    Hirshaut Y; Kesselheim H
    Cancer; 1983 Jun; 51(11):1998-2004. PubMed ID: 6687698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A randomized trial comparing ACF (adriamycin, cyclophosphamide, ftorafur) and ACF/MVMF (mitomycin C, vincristine, methotrexate, ftorafur)--a non-cross-resistant alternating chemotherapy of recurrent and advanced breast cancer].
    Mukaiyama T; Ogawa M; Horikoshi N; Inoue K; Tada A; Ueno K; Yamazaki H; Nakamura T; Ito Y; Inagaki J
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):327-32. PubMed ID: 2494947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Sordillo PP; Cheng EW
    Am J Clin Oncol; 1984 Oct; 7(5):529-33. PubMed ID: 6391145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin C and vinblastine chemotherapy for advanced breast cancer.
    Konits PH; Aisner J; van Echo DA; Lichtenfeld K; Wiernik PH
    Cancer; 1981 Sep; 48(6):1295-8. PubMed ID: 6791808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with BCNU, vincristine, mitomycin-C and prednisone in refractory breast carcinoma. A pilot study.
    DiBella NJ; Garfield D; Fink K; Anderson P; Speer J; Murphy J
    Oncology; 1984; 41(1):1-3. PubMed ID: 6422372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VAP-cyclo: a short intensive regimen of chemotherapy for advanced breast cancer.
    Bramwell VH; Howell A; Scarffe H; Crowther D; Sellwood RA
    Cancer Treat Rep; 1982 Nov; 66(11):1999-2000. PubMed ID: 6897207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.